PharmTech Talk

May 23, 2017
By Pharmaceutical Technology Editors
CBER is moving forward with the development and approval of regenerative medicine advanced therapies.
May 09, 2017
User fee reauthorizations, a hiring freeze, and opioid epidemic await the new FDA commissioner Scott Gottlieb.
May 09, 2017
FDA hopes to better use global resources and avoid duplicate inspections of foreign facilities.
Apr 06, 2017
FDA is in the center of the debate over developing and pricing new cancer therapies.
Apr 06, 2017
The role of patient advocates in shaping regulations and policy has put attention on financial and operational links between drug companies and independent health organizations.
Apr 05, 2017
Scott Gottlieb answers Senators' questions at his confirmation hearing before the Senate Health, Education, Labor and Pensions Committee.
Mar 28, 2017
A new report states that wider access to new antivirals for HCV and better screening of patients would help avert 90,000 deaths by 2030.
Mar 27, 2017
Manufacturers and regulators are working to reach consensus on the harmonization of management of postapproval changes.
Mar 22, 2017
Will new generic drugs bring the cost of medicines down in the way policy makers hope?
Mar 13, 2017
Trump’s choice for FDA commissioner faces drug pricing, regulatory, and approval challenges.
lorem ipsum